karppaus.info

Beginning in January 2022, Humana will include Virta’s treatment as an option for large, self-funded Employer Groups. The treatment, a first-of-its-kind, is designed to help people reverse their type 2 diabetes through individualized nutritional therapy and continuous remote medical care—allowing patients to achieve normal blood sugar while eliminating the need for diabetes-specific medications.

Episode # 145 – Type 2 Diabetes is Reversible. Virta Health is Eliminating or Reducing Insulin for 93% of Patients in the Largest & Longest Study of its Kind. Adopted by 200 Large Plans and Growing Fast. Dr. Frank Dumont, Virta Health’s Commercial Medical Director, Lays it Out.

Nearly half of Virta's insurer partners—including Humana and Providence Health Plan—now offer diabetes reversal to their self-funded employer groups.

SAN FRANCISCO--(BUSINESS WIRE)--Today Virta Health, the leader in type 2 diabetes reversal, announced it now works with more than 20 national and regional health plans, marking 133% year-over-year growth with large insurer customers. Of these partners, nearly half—including Humana and Providence Health Plan—now offer Virta’s diabetes reversal treatment to their self-funded employer groups, representing thousands of companies and over 5M covered lives.

“The tide is turning towards disease reversal as the primary goal for type 2 diabetes treatment”

Heightened demand for Virta coincides with an industry-wide shift towards reversal as an antidote to America’s worsening metabolic disease epidemic. Virta’s clinically proven treatment upends traditional approaches, and helps patients normalize blood sugar while removing the need for expensive medications like insulin. Recent analysis, with methodology validated by the independent actuarial firm Milliman, Inc., demonstrated payer savings of $425 per Virta patient per month, or $10,000 over the first two years.

“The tide is turning towards disease reversal as the primary goal for type 2 diabetes treatment,” said Sami Inkinen, CEO and co-founder of Virta. “Our accelerating health plan growth affirms this shift, as payers race to cut costs while helping patients transform their health.”

Recognizing this transition, the American Diabetes Association, the Endocrine Society, the European Association for the Study of Diabetes, and Diabetes UK recently released a consensus report that defined diabetes reversal for the first time while refining remission criteria.

Alongside health plan growth, Virta is also rapidly expanding its reach with employer customers. Over the last year alone, Virta has seen triple-digit year-over-year growth for its enterprise business.

To learn more about how Virta’s diabetes reversal offering can save money and improve the health of your population, reach out to ​​partner@virtahealth.com

The company, called Virta Health, offers a clinically-studied treatment to safely and sustainably reverse type 2 diabetes. Its technology platform is built on decades of research on human metabolic disorders, new developments in epigenetics and genomics, and advances in mobile technology. To start, prospective patients enroll in the Virta Clinic, where they are assigned to an expert clinical team that delivers care safely and effectively. That’s where Virta’s unique role comes in.